Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/1995
11/09/1995CA2189067A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
11/09/1995CA2189052A1 Compositions and method of stimulating the proliferation and differentiation of human fetal and adult pancreatic cells ex vivo
11/09/1995CA2189032A1 Enhancing the sensitivity of tumor cells to therapies
11/09/1995CA2188648A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
11/09/1995CA2188647A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995CA2187088A1 Immortalized and malignant human prostatic cell lines
11/08/1995EP0680517A1 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995EP0680511A1 Acetyl-coa-carboxylase-gene
11/08/1995EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995EP0423240B1 Modulation of virus-host cell interactions using cyclic oligosaccharides
11/08/1995EP0419574B1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
11/08/1995EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
11/07/1995US5464763 Infection with Agrobacterium, plasmids with and without T-regions and vir-regions of tumor inducing plasmid
11/07/1995CA1337518C Monoclonal antibodies against tnf-–, hybridomas producing them and method for the purification of tnf-–
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029237A1 Cardiotrophin and uses therefor
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029235A1 Spider neurotoxins and method of producing the same
11/02/1995WO1995029234A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
11/02/1995WO1995029233A1 ISOLATED NUCLEIC ACID MOLECULE CODING FOR FIBROBLAST ACTIVATION PROTEIN α AND USES THEREOF
11/02/1995WO1995029231A1 Serum-free medium supplement
11/02/1995WO1995029230A1 Culture medium for maintaining viability of mammalian cells
11/02/1995WO1995029193A2 Melanoma antigens
11/02/1995WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995EP0679888A2 Method for determining capability of imparting growth activity
11/02/1995EP0679402A2 Biologically active substance-secreting hybrid gel
11/02/1995EP0679256A1 Method to distinguish hematopoietic progenitor cells
11/02/1995EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
11/02/1995EP0404967B1 Recombinant c-terminal alpha-amidating enzyme of human thyroid origin
11/02/1995DE19504958C1 Appts. and method for the cultivation of cells on a carrier
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995CA2188258A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
11/02/1995CA2187920A1 Spider neurotoxins and method of producing the same
11/02/1995CA2186608A1 Serum-free medium supplement
10/1995
10/31/1995US5463175 Glyphosate tolerant plants
10/31/1995US5463026 Anti-human prohibitin antibodies
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462872 Human lymphoid cells expressing human immunodeficiency virus envelope protein GP160
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/31/1995US5462870 Human diploid salivary gland epithelial cell lines
10/31/1995US5462856 Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
10/29/1995CA2147801A1 Method for determining capability of imparting growth activity
10/28/1995CA2147933A1 Transgenic animals as a model for metabolic bone diseases
10/26/1995WO1995028494A1 Gene delivery fusion proteins
10/26/1995WO1995028492A1 Dna regulatory elements responsive to cytokines
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028482A2 Dna spacer regulatory elements responsive to cytokines and methods for their use
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028479A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process
10/26/1995WO1995028478A1 Rps2 gene and uses thereof
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028423A1 Rps gene family, primers, probes, and detection methods
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995WO1995028167A1 Methods of treating disease using sertoli cells and allografts or xenografts
10/26/1995WO1995028166A2 Method for implanting encapsulated cells in a host
10/26/1995WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995CA2187818A1 Gene delivery fusion proteins
10/26/1995CA2187771A1 Rps gene family, primers, probes, and detection methods
10/26/1995CA2187770A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2187335A1 Method for implanting encapsulated cells in a host
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995CA2165057A1 Dna spacer regulatory elements responsive to cytokines and methods for their use
10/26/1995CA2147810A1 Biologically active substance-secreting hybrid gel
10/26/1995CA2139724A1 High speed flow cytometric separation of viable cells
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/24/1995US5460964 Maintaining population of human hematopoetic cells in a non-contacting relationship to a population of cultured stromal cells which is liquid stromal cell culture medium comprising interleukin-3 and macrophase inflammatory protein-1-alpha
10/24/1995US5460963 Plants transformed with a DNA sequence from Bacillus thuringiensis lethal to Lepidoptera
10/24/1995US5460953 Vectors and compounds for expression of glycosylation mutants of human protein C
10/24/1995US5460952 Gene expression system comprising the promoter region of the α-amylase genes
10/24/1995US5460950 Expression of PACE in host cells and methods of use thereof
10/24/1995US5460947 Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas
10/24/1995US5460939 Temporary living skin replacement
10/24/1995US5460815 Culturing Crandall Feline Kidney cells infected with Dahlberg strain feline infectious peritonitis virus in serum containing growth medium, transferring it to serum-free growth medium, separating viral precursor immunogens, inactivating live virus
10/24/1995CA1337406C Regeneration and transformation of cotton
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027791A1 Plant lysophosphatidic acid acyltransferases
10/19/1995WO1995027790A2 DNA SEQUENCES CODING FOR A CYNNAMOYL CoA REDUCTASE AND THEIR USE IN THE REGULATION OF PLANT LIGNIN CONCENTRATIONS
10/19/1995WO1995027786A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027722A1 Interleukin-15
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4
10/19/1995CA2187336A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995CA2185334A1 Dna sequences coding for a cynnamoyl coa reductase and their use in the regulation of plant lignin concentrations
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
1 ... 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 ... 1827